Lochmuller Lab clinical research webpage update

It’s now easier than ever to stay up-to-date on the clinical research trials that our team is involved in

We are excited to share an update to the clinical research page on the Lochmüller Lab website! With a new searchable list of the ongoing clinical trials at our adult and pediatric sites in Ottawa, the clinical research page serves as an informational hub for all stakeholders who wish to learn more about the clinical research work conducted by the team. Visit the clinical research page to view the interactive table.

The new clinical trials list provides searchable and filterable information on the current trials the research team are involved in.

 

Clinical trial research

Dr Hanns Lochmüller sees adult neuromuscular patients at the Ottawa Neuromuscular Centre at The Ottawa Hospital, providing consultations and opportunities to participate in clinical research; he also sees pediatric neuromuscular patients at the Children’s Hospital of Eastern Ontario (CHEO), providing consultations and opportunities to participate in clinical research.

In 2022 pediatric neurologist and neuromuscular specialist Dr Hugh McMillan returned to CHEO after a period working in Montreal. Dr McMillan and Dr Lochmüller work closely together on pediatric neuromuscular research at CHEO, supported by neurologist Dr Alberto Aleman. This provides further opportunities for pediatric neuromuscular patients to participate in clinical trials. The research coordinators work as a joint team helping to run clinical studies for both doctors.

How to contact us

More information on how to contact the clinical team is available on the clinical research page, and we encourage patients, investigators, and industry members to contact our clinical research team to learn more about our work.

 

 

The new clinical trials list provides searchable and filterable information on the current trials the research team are conducting.

Read next...

New lab publication on riboflavin transporter deficiency model

New Publication: Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish

Riboflavin transporter deficiency (RTD) is a rare genetic disorder in children, characterised by progressive sensorimotor and cranial neuronopathy caused by mutations in riboflavin transporter protein-encoding...
Congratulations CNMD Ottawa on 25 years of neuromuscular research. Photo of all former and current directors of the Centre.

uOttawa Eric Poulin Centre for Neuromuscular Disease Celebrates 25 Years of Neuromuscular Research

New co-directors Dr Mireille Khacho and Dr Hanns Lochmüller begin their tenure On November 25th the University of Ottawa Eric Poulin Centre for Neuromuscular Disease...
Clinical trial update - Canadian Patient First in the World to Receive Trial Drug in Argenx DOK7-CMS Study

Canadian Patient Dosed in Argenx DOK7-CMS Study

Our clinical research team at the NeuroMuscular centre of The Ottawa Hospital is excited to share that a Canadian patient affected by DOK-7 Congenital Myasthenic...
New lab publication - Brain malformations and seizures by impaired chaperonin function of TRiC

New Publication: Brain malformations and seizures by impaired chaperonin function of TRiC

We are excited to share a new publication from our research team! The study “Brain malformations and seizures by impaired chaperonin function of TRiC” uncovers...
New leadership for the University of Ottawa Centre for Neuromuscular Disease, Drs Mireille Khacho and Hanns Lochmuller.

Drs Hanns Lochmüller and Mireille Khacho New Leaders of University of Ottawa Eric Poulin Centre for Neuromuscular Disease

We are delighted to share exciting news from the uOttawa Brain and Mind Research Institute (uOBMRI)! Drs. Hanns Lochmüller and Mireille Khacho have been appointed...
Dr Lola Lessard and Kelly Ho receive prestigious research poster awards

Lab Members Receive Research Poster Awards at National and International Conferences

Kelly Ho Receives Poster Award at World Muscle Society Congress Congratulations to PhD researcher Kelly Ho, whose poster presentation "Investigating muscle specific kinase antibody treatment...